Josh Gottheimer
Josh Gottheimer (D-NJ) sold $15K-$50K of $MRK (Merck & Company, Inc. Common Stock (MRK)) on Jan 27, 2025, part of 81 transactions in this filing (41 buys, 40 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
5 flagsRep. Gottheimer made two purchases of Mastercard (MA) totaling $2,002-$30,000 on Jan 30-31, 2025 — 5-6 days before the Fair Access to Banking Act (HR987) was introduced, a bill directly regulating bank and payment network standards.
Rep. Gottheimer purchased Visa (V) five times for a combined $5,005-$75,000 between Jan 23-31, 2025 — 5-13 days before the Fair Access to Banking Act (HR987) was introduced, which sets quantitative risk rules for payment networks.
Rep. Gottheimer purchased $1,001-$15,000 in 3M (MMM) on Jan 30, 2025 — 13 days before the Water Systems PFAS Liability Protection Act (HR1267) was introduced, a bill that could reduce 3M's liability exposure for PFAS contamination.
Rep. Gottheimer purchased $1,001-$15,000 in Johnson & Johnson (JNJ) on Jan 24, 2025 — 13 days before the Growing and Preserving Innovation in America Act (HR1062) was introduced, which would lock in lower tax rates that benefit multinationals like J&J.
Rep. Gottheimer sold $1,001-$15,000 in Microsoft (MSFT) on Jan 21 and again on Jan 31, 2025 — 5-15 days before the No Tax Breaks for Outsourcing Act (S409) was introduced, which would raise taxes on foreign profits held by companies like Microsoft.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $MMM | 3M Company Common Stock (MMM) | $1K-$15K | — | $146.03 | — | Jan 30, 2025 |
| BUY | $MMM | 3M Company Common Stock (MMM) | $1K-$15K | — | $146.03 | — | Jan 21, 2025 |
| BUY | $ABT | Abbott Laboratories Common Stock (ABT) | $1K-$15K | $127.86 | — | — | Jan 29, 2025 |
| BUY | $ABT | Abbott Laboratories Common Stock (ABT) | $1K-$15K | $127.86 | — | — | Jan 28, 2025 |
| BUY | $BABA | Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) | $1K-$15K | — | — | — | Jan 31, 2025 |
| BUY | $BABA | Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) | $1K-$15K | — | — | — | Jan 16, 2025 |
| BUY | $ABEV | Ambev S.A. American Depositary Shares (ABEV) | $1K-$15K | $1.83 | — | — | Jan 27, 2025 |
| BUY | $BRK.B | Berkshire Hathaway Inc. New Common Stock (BRK.B) | $1K-$15K | — | — | — | Jan 16, 2025 |
| BUY | $CDRE | Cadre Holdings, Inc. Common Stock (CDRE) | $1K-$15K | $39.84 | — | — | Jan 27, 2025 |
| BUY | $KO | Coca-Cola Company (KO) | $1K-$15K | $62.25 | — | — | Jan 16, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Unplug the Electric Vehicle Charging Stations Program Act
H.R. 1513 targets $7.5 billion in federal EV charging grants for repeal. The bill is in early committee stage but has a companion Senate bill, increasing its probability of advancement. Pure-play charging companies EVgo, ChargePoint, and Blink face direct revenue risk from the loss of NEVI and CFI capital co-funding. Tesla faces indirect headwinds from slower EV adoption, though its proprietary Supercharger network and vehicle sales buffer the impact.
Fair Access to Banking Act
HR987, the Fair Access to Banking Act, is an early-stage bill with 92 cosponsors that has been referred to committee with no hearings or markups. With no funding authorization and manageable incremental compliance costs, market impact is minimal. Financial sector stocks show no price movement attributable to this bill. JPMorgan ($312.83) has gained 6.35% in 30 days and Bank of America ($53.27) has gained 9.25% in 30 days on broader sector strength, not this legislation.
Water Systems PFAS Liability Protection Act
HR1267 is an early-stage bill exempting water utilities from CERCLA liability for PFAS, shifting cleanup costs to chemical manufacturers. The bill is in committee with 26 cosponsors and no floor action. Water utility stocks ($WTRG at $39.49, $CWT at $45.38) show mixed near-term trends; no market reaction to this bill is observable. Chemical manufacturers $DD at $44.62 and $MMM at $143.87 face potential increased liability exposure but remain near their 52-week ranges.
No Tax Breaks for Outsourcing Act
The No Tax Breaks for Outsourcing Act (S409) would eliminate tax deferral on foreign profits for U.S. multinationals, increasing effective tax rates by 5-8 percentage points. The bill is in early stages (referred to Senate Finance Committee, 19 cosponsors) and poses a 4-8% annual net income headwind for high international-exposure companies. Despite 8-30% rallies in the last 30 days across MSFT, AAPL, GOOGL, KO, PG, XOM, and CVX, this legislative risk is not currently priced into valuations.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HR1492 retroactively extends the Medicare price negotiation safe harbor for small-molecule drugs from 7 to 11 years, matching biologics. This shields billions in revenue for major pharma companies, particularly pure-play small-molecule firms like Vertex and large players with top-selling Part D drugs like Pfizer, Bristol-Myers Squibb, and Gilead. The bill is early-stage with 67 cosponsors and a Republican sponsor, giving it moderate momentum.
Health Care Providers Safety Act of 2025
HR 612 is an early-stage authorization bill with zero appropriated funding. Market impact is minimal until a separate appropriations bill passes. The bill signals Congressional intent to support healthcare security spending but creates no immediate revenue for cybersecurity or physical security companies.
Defending Domestic Orange Juice Production Act of 2025
HR933 proposes reducing the FDA standard for orange juice soluble solids from 10.5% to 10.0%, a direct regulatory cost savings for major OJ producers. The bill is early-stage but has strong bipartisan Florida delegation support with 25 cosponsors. $KO, $PEP, and $KDP are the primary beneficiaries, with recent price trends showing a broad market recovery rather than bill-specific movement.
Growing and Preserving Innovation in America Act of 2025
HR1062 permanently locks in higher FDII and GILTI deductions for US multinationals, preventing a ~3.3 ppt effective tax rate increase on foreign IP income scheduled for 2026. This directly boosts after-tax net income for companies with large international revenue streams, including MSFT, AAPL, GOOGL, AMZN, NVDA, JNJ, PFE, KO, and PG. The bill is in early committee stage — structural impact is contingent on passage through the 119th Congress.
American Innovation Act of 2025
Bill HR1778 would increase tax deductions for startup costs from $5k to $20k, reducing the net first-year burden for new enterprises. This quantitatively expands the customer base for business-formation beneficiary companies like Intuit ($INTU), Wix ($WIX), and PayPal ($PYPL). Current market data shows these three tickers have experienced near-term price declines (7-day changes of -2.07%, -1.55%, -1.17% respectively), making them cheaper entries ahead of potential bill momentum later in 2026.
Repeal Community Development Block Grants Act of 2025
HR1133 is an early-stage bill to eliminate the Community Development Block Grant program. Passage probability is very low given single sponsorship and no committee action since referral. Bearish for homebuilders reliant on subsidized infrastructure, but near-term market impact is negligible.
Other Filings by Josh Gottheimer
Free — no credit card
Get the next Gottheimer trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.